Christopher Kroeger is President and Chief Executive Officer of MapLight Therapeutics, Inc. (MPLT). The company reported total compensation of $25,624,254 for fiscal year 2025.
| Salary | $655,250 |
|---|---|
| Bonus | $0 |
| Stock awards | $12,296,267 |
| Option awards | $12,322,406 |
| Non-equity incentive plan | $331,000 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $19,331 |
| Total | $25,624,254 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure MapLight Therapeutics, Inc. filed April 29, 2026, accession 0001193125-26-191449.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Christopher Kroeger this page | President and Chief Executive Officer | $25,624,254 |
| Erin Foff | Chief Medical Officer | $6,254,000 |
| Vishwas Setia | Chief Financial Officer | $6,202,564 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full MapLight Therapeutics, Inc. compensation brief.
Christopher Kroeger's compensation sits inside MapLight Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.